ICICI Securities's research report on 3M India
3M India’s EBITDA margin of 14.1% in Q3FY25 was at its lowest since the past nine quarters. We believe INR depreciation and higher freight cost impacted 3M’s margins. While the healthcare segment reported strong growth with margin expansion, we note all other segments reported EBIT margin contraction. We believe, the trend of strong growth in healthcare and weakness in other segments may continue for the next 2–3 quarters. We also model the INR depreciation to impact margins in H1CY25. Weakness in the automotive sector (key client sector for 3M India) may also impact margins in FY26. We remain positive on 3M India led by established competitive advantages and long-term growth potential. We cut FY25-26 estimates by 3–5% to factor in weaker-than-expected Q3FY25 and a likely slow-down in the automotive sector in FY26-27. With ~30% correction in stock price over the past six months, we believe there is valuation support at current market price. We remain constructive. Retain BUY.
Outlook
We model 3M India to report revenue and PAT CAGRs of 9.5% and 9.2%, respectively, over FY24-27E with RoE> Cost of capital. We value the stock as per the DCF methodology with a revised TP of INR 33,500 (implied target P/E of 50x 27E; earlier: INR 40,410). Risks: Steep increase in competitive pressure and commodity inflation.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.